Insider Actions for Gilead Sciences Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 05/03/2023 |
Kevin E. Lofton Director |
1,887 | Award at $0 per share. | 0 |
| 05/03/2023 |
Jacqueline K. Barton Director |
1,887 | Award at $0 per share. | 0 |
| 05/03/2023 |
Harish M. Manwani Director |
1,887 | Award at $0 per share. | 0 |
| 05/03/2023 |
Javier J. Rodriguez Director |
1,887 | Award at $0 per share. | 0 |
| 05/03/2023 |
Anthony Welters Director |
1,887 | Award at $0 per share. | 0 |
| 05/03/2023 |
Sandra J. Horning Director |
1,887 | Award at $0 per share. | 0 |
| 05/03/2023 |
Harish M. Manwani Director |
368 | Derivative/Non-derivative trans. at $79.45 per share. | 29,237 |
| 05/01/2023 |
Kevin E. Lofton Director |
12,868 | Gift at $0 per share. | 0 |
| 03/13/2023 |
Merdad V. Parsey Chief Medical Officer |
6,126 | Disposition at $78.99 per share. | 483,892 |
| 03/10/2023 |
Daniel P. O'Day Chairman & CEO; Director |
14,017 | Derivative/Non-derivative trans. at $79.5 per share. | 1,114,351 |
| 03/10/2023 |
Andrew D. Dickinson Chief Financial Officer |
4,849 | Derivative/Non-derivative trans. at $79.5 per share. | 385,495 |
| 03/10/2023 |
Johanna Mercier Chief Commercial Officer |
5,116 | Derivative/Non-derivative trans. at $79.5 per share. | 406,722 |
| 03/10/2023 |
Merdad V. Parsey Chief Medical Officer |
5,328 | Derivative/Non-derivative trans. at $79.5 per share. | 423,576 |
| 03/10/2023 |
Sandra K. Patterson SVP, Controllership |
801 | Derivative/Non-derivative trans. at $79.5 per share. | 63,679 |
| 03/10/2023 |
Daniel P. O'Day Chairman & CEO; Director |
10,800 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2023 |
Daniel P. O'Day Chairman & CEO; Director |
19,488 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2023 |
Andrew D. Dickinson Chief Financial Officer |
7,394 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2023 |
Andrew D. Dickinson Chief Financial Officer |
3,025 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2023 |
Johanna Mercier Chief Commercial Officer |
7,951 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2023 |
Johanna Mercier Chief Commercial Officer |
3,025 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2023 |
Merdad V. Parsey Chief Medical Officer |
7,999 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2023 |
Merdad V. Parsey Chief Medical Officer |
3,455 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2023 |
Sandra K. Patterson SVP, Controllership |
1,320 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/10/2023 |
Sandra K. Patterson SVP, Controllership |
1,601 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/09/2023 |
Kevin E. Lofton Director |
8,442 | Derivative/Non-derivative trans. at $52.38 per share. | 442,191 |
| 03/01/2023 |
Daniel P. O'Day Chairman & CEO; Director |
4,842 | Derivative/Non-derivative trans. at $79.59 per share. | 385,374 |
| 03/01/2023 |
Merdad V. Parsey Chief Medical Officer |
12,984 | Disposition at $79.96 per share. | 1,038,200 |
| 03/01/2023 |
Daniel P. O'Day Chairman & CEO; Director |
11,362 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 02/15/2023 |
Andrew D. Dickinson Chief Financial Officer |
376 | Award at $56.38 per share. | 21,198 |
| 02/15/2023 |
Merdad V. Parsey Chief Medical Officer |
376 | Award at $56.38 per share. | 21,198 |
| 02/15/2023 |
Deborah H. Telman EVP, Corporate Affairs & GC |
376 | Award at $56.38 per share. | 21,198 |
| 02/06/2023 |
Andrew D. Dickinson Chief Financial Officer |
531 | Derivative/Non-derivative trans. at $86.36 per share. | 45,857 |
| 02/06/2023 |
Diane E. Wilfong SVP, Controller & CAO |
565 | Derivative/Non-derivative trans. at $86.36 per share. | 48,793 |
| 02/06/2023 |
Andrew D. Dickinson Chief Financial Officer |
1,817 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 02/06/2023 |
Diane E. Wilfong SVP, Controller & CAO |
1,864 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/24/2023 |
Daniel P. O'Day Chairman & CEO; Director |
59,078 | Derivative/Non-derivative trans. at $84.02 per share. | 4,963,733 |
| 01/24/2023 |
Andrew D. Dickinson Chief Financial Officer |
15,327 | Derivative/Non-derivative trans. at $84.02 per share. | 1,287,774 |
| 01/24/2023 |
Johanna Mercier Chief Commercial Officer |
15,325 | Derivative/Non-derivative trans. at $84.02 per share. | 1,287,606 |
| 01/24/2023 |
Merdad V. Parsey Chief Medical Officer |
17,749 | Derivative/Non-derivative trans. at $84.02 per share. | 1,491,270 |
| 01/24/2023 |
Diane E. Wilfong SVP, Controller & CAO |
1,244 | Derivative/Non-derivative trans. at $84.02 per share. | 104,520 |
| 01/24/2023 |
Daniel P. O'Day Chairman & CEO; Director |
136,647 | Award at $0 per share. | 0 |
| 01/24/2023 |
Daniel P. O'Day Chairman & CEO; Director |
78,370 | Award at $0 per share. | 0 |
| 01/24/2023 |
Andrew D. Dickinson Chief Financial Officer |
38,270 | Award at $0 per share. | 0 |
| 01/24/2023 |
Andrew D. Dickinson Chief Financial Officer |
27,932 | Award at $0 per share. | 0 |
| 01/24/2023 |
Johanna Mercier Chief Commercial Officer |
38,270 | Award at $0 per share. | 0 |
| 01/24/2023 |
Johanna Mercier Chief Commercial Officer |
29,124 | Award at $0 per share. | 0 |
| 01/24/2023 |
Merdad V. Parsey Chief Medical Officer |
43,715 | Award at $0 per share. | 0 |
| 01/24/2023 |
Merdad V. Parsey Chief Medical Officer |
29,644 | Award at $0 per share. | 0 |
| 01/24/2023 |
Diane E. Wilfong SVP, Controller & CAO |
4,100 | Award at $0 per share. | 0 |
| 01/24/2023 |
Diane E. Wilfong SVP, Controller & CAO |
1,784 | Award at $0 per share. | 0 |
| 12/30/2022 |
Merdad V. Parsey Chief Medical Officer |
553 | Disposition at $85.33 per share. | 47,187 |
